Menu
Back to User profile » Dr Steven Feldman
Papers published by Dr Steven Feldman:
Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
Kelly KA, Perche PO, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2022, 15:1037-1043
Published Date: 3 June 2022
Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
Light JG, Su JJ, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2021, 14:55-63
Published Date: 15 January 2021
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR
ImmunoTargets and Therapy 2020, 9:255-272
Published Date: 10 November 2020
Accountability in patient adherence
Oussedik E, Cline A, Su JJ, Masicampo EJ, Kammrath LK, Ip E, Feldman SR
Patient Preference and Adherence 2019, 13:1511-1517
Published Date: 4 September 2019
Treatment-resistant prurigo nodularis
Kolli SS, Haidari W, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2019, 12:345-346
Published Date: 9 May 2019
Satisfied patients and pediatricians: a cross-sectional analysis
Patel I, Chapman T, Camacho F, Shrestha S, Chang J, Balkrishnan R, Feldman SR
Patient Related Outcome Measures 2018, 9:299-307
Published Date: 28 August 2018
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
Wechter T, Cline A, Feldman SR
Therapeutics and Clinical Risk Management 2018, 14:1489-1497
Published Date: 22 August 2018
Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review
Murage JM, Tongbram V, Feldman SR, Malatestinic WN, Larmore CJ, Muram TM, Burge RT, Bay C, Johnson N, Clifford S, Araujo AB
Patient Preference and Adherence 2018, 12:1483-1503
Published Date: 21 August 2018
Current treatment options for acanthosis nigricans
Patel NU, Roach C, Alinia H, Huang WW, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2018, 11:407-413
Published Date: 7 August 2018
Barriers to treatment: describing them from a different perspective
Devine F, Edwards T, Feldman SR
Patient Preference and Adherence 2018, 12:129-133
Published Date: 17 January 2018
Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review
Patel NU, Felix K, Reimer D, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2017, 10:385-391
Published Date: 29 September 2017
Accountability: a missing construct in models of adherence behavior and in clinical practice
Oussedik E, Foy CG, Masicampo EJ, Kammrath LK, Anderson RE, Feldman SR
Patient Preference and Adherence 2017, 11:1285-1294
Published Date: 25 July 2017
Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability
Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR
Patient Preference and Adherence 2017, 11:1143-1150
Published Date: 6 July 2017
Ethical considerations in adherence research
Patel NU, Moore BA, Craver RF, Feldman SR
Patient Preference and Adherence 2016, 10:2429-2435
Published Date: 5 December 2016
Interventions to increase adherence to acne treatment
Moradi Tuchayi S, Alexander TM, Nadkarni A, Feldman SR
Patient Preference and Adherence 2016, 10:2091-2096
Published Date: 11 October 2016
New developments in the treatment of rosacea – role of once-daily ivermectin cream
Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2016, 9:71-77
Published Date: 18 March 2016
Internet-based adherence interventions for treatment of chronic disorders in adolescents
Bass AM, Farhangian ME, Feldman SR
Adolescent Health, Medicine and Therapeutics 2015, 6:91-99
Published Date: 26 May 2015
Clinical potential of brodalumab in the management of psoriasis: the evidence to date
Sandoval LF, Williams B, Feldman SR
Psoriasis: Targets and Therapy 2015, 5:35-41
Published Date: 11 March 2015
Emerging treatment options for psoriasis
Taheri A, Sandoval LF, Moradi Tuchayi S, Alinia H, Mansoori P, Feldman SR
Psoriasis: Targets and Therapy 2014, 4:27-35
Published Date: 18 August 2014
Self-management in patients with psoriasis
Pathak SN, Scott PL, West C, Feldman SR
Psoriasis: Targets and Therapy 2014, 4:19-26
Published Date: 10 July 2014
Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation
Shepherd J, Taheri A, Feldman SR
Clinical, Cosmetic and Investigational Dermatology 2014, 7:19-22
Published Date: 19 December 2013
The effect of reminder systems on patients' adherence to treatment
Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR
Patient Preference and Adherence 2012, 6:127-135
Published Date: 10 February 2012